Lignans from Dysosma versipellis with Inhibitory Effects on Prostate Cancer Cell Lines
A new monoepoxylignan, dysosmarol (1), along with eight known compounds, podophyllotoxin (2), 4‘-demethylpodophyllotoxin (3), deoxypodophyllotoxin (4), 4‘-demethyldeoxypodophyllotoxin (5), diphyllin (6), kaempferol, quercetin, and β-sitosterol, were isolated from the roots of Dysosma versipellis. Th...
Saved in:
Published in | Journal of natural products (Washington, D.C.) Vol. 70; no. 2; pp. 283 - 286 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
WASHINGTON
American Chemical Society
01.02.2007
Amer Chemical Soc American Society of Pharmacognosy |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new monoepoxylignan, dysosmarol (1), along with eight known compounds, podophyllotoxin (2), 4‘-demethylpodophyllotoxin (3), deoxypodophyllotoxin (4), 4‘-demethyldeoxypodophyllotoxin (5), diphyllin (6), kaempferol, quercetin, and β-sitosterol, were isolated from the roots of Dysosma versipellis. The structure of 1 was elucidated by spectroscopic methods. Aryltetralin lignans 2−4 showed the most potent inhibitory activities against the growth of androgen-sensitive (LNCaP) and androgen-independent (PC-3) human prostate cancer cell lines, with IC50 values in the ranges 0.030−0.056 and 0.032−0.082 μM, respectively. A quantitative HPLC analysis showed that compound 2 occurred at the highest concentration in the plant (37.21 mg/g) followed by compound 4 (5.01 mg/g) and compound 3 (2.75 mg/g). Furthermore, D. versipellis roots contain a similar content of compound 2 as compared with the rhizomes and roots of Podophyllum hexandrum, a commercial source of the lignan. Thus, cultivation of D. versipellis in suitable locations may serve as an alternative source for podophyllotoxin (2) production. |
---|---|
Bibliography: | http://dx.doi.org/10.1021/np060430o ark:/67375/TPS-F7K03J90-R istex:F3B2775DD3604861D29FD080AD9BAF78D976F246 Dedicated to Professor Thomas C. W. Mak of the Chinese University of Hong Kong on the occasion of his 70th birthday. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Harvard Medical School. Jinan University. Hong Kong Jockey Club Institute of Chinese Medicine. The Chinese University of Hong Kong. |
ISSN: | 0163-3864 1520-6025 |
DOI: | 10.1021/np060430o |